Completed
Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg
NCT02955472
- Conditions
- Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +11 more
- Locations
-
- Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea